Mar 24, 2020 / 08:30PM GMT
Operator
Good afternoon, and welcome to Onconova Therapeutics Corporate Update and Full Year 2019 Financial Results Conference Call. (Operator Instructions) As a reminder, this call may be recorded.
At this time, I would like to turn the call over to Avi Oler, Senior Vice President of Corporate Development and General Counsel.
Abraham N. Oler - Onconova Therapeutics, Inc. - VP of Corporate Development & General Counsel
Thank you, operator. Good afternoon, and welcome to Onconova's fourth quarter and full year 2019 corporate update and financial results conference call. Earlier this afternoon, we issued a press release outlining our financial results and business progress during the year. If you have not seen this press release, it is available on the Investor Relations page of our website at www.onconova.com.
On today's call, Dr. Steve Fruchtman, President and CEO, will discuss the company's recent highlights and anticipated clinical and business milestones. After Steve completes his
Q4 2019 Onconova Therapeutics Inc Earnings Call Transcript
Feb 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers